secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coya Therapeutics, Inc. (COYA)
CIK:        0001835022
Form:       8-K
Filed at:   2023-06-29T23:59:59+00:00
Accession:  0001193125-23-178604
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Coya Therapeutics annual meeting: Garren elected director, auditor ratified
---------------------------------------------------------------------------

- Hideki Garren elected Class I director with 3,414,906 for, 405,471 withheld, 221,601 broker non-votes.
- Ratification of Weaver & Tidwell as independent auditor received 4,008,651 for, 31,504 against, 1,823 abstain.
- All proposals passed at the June 28, 2023 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835022/000119312523178604/0001193125-23-178604-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835022/000119312523178604/d531146d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-178604

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer